Literature DB >> 11435901

Association studies using novel polymorphisms in BACE1 and BACE2.

P Nowotny1, J M Kwon, S Chakraverty, V Nowotny, J C Morris, A M Goate.   

Abstract

The release of amyloid-beta peptide (Abeta) from beta-amyloid precursor protein (APP) requires cleavage by beta- and gamma-secretases. Several groups have identified a candidate for the beta-site APP-cleaving enzyme, BACE1, and its homologue BACE2. We sequenced the genes for BACE1 and BACE2 and found several polymorphisms in both genes. Genotyping a large cohort of AD cases and controls has shown no association between AD and the intronic polymorphism in BACE2 while there was a weak association between the BACE1 polymorphism in exon 5 and AD in those carrying the APOE epsilon4 allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435901     DOI: 10.1097/00001756-200107030-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer's disease.

Authors:  Weihui Zhou; Fang Cai; Yu Li; George S Yang; Kathleen D O'Connor; Robert A Holt; Weihong Song
Journal:  J Mol Neurosci       Date:  2010-05-09       Impact factor: 3.444

2.  Characterization of the human beta-secretase 2 (BACE2) 5'-flanking region: identification of a 268-bp region as the basal BACE2 promoter.

Authors:  Bryan Maloney; Yuan-Wen Ge; Nigel H Greig; Debomoy K Lahiri
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  BACE1 polymorphisms do not influence platelet membrane beta-secretase activity or genetic susceptibility for Alzheimer's disease in the Northern Irish population.

Authors:  S Todd; A J McKnight; W W Liu; R Carson; S Heggarty; B McGuinness; G B Irvine; D Craig; A P Passmore; J A Johnston
Journal:  Neuromolecular Med       Date:  2008-06-26       Impact factor: 3.843

4.  Genetic association of BACE1 gene polymorphism C786G with late-onset Alzheimer's disease in Chinese.

Authors:  Rui Kan; Binbin Wang; Chuanfang Zhang; Feng Jin; Ze Yang; Shun Ji; Zeping Lu; Chenguang Zheng; Li Wang
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease.

Authors:  Annica Sjölander; Henrik Zetterberg; Ulf Andreasson; Lennart Minthon; Kaj Blennow
Journal:  Mol Neurodegener       Date:  2010-09-17       Impact factor: 14.195

6.  Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.

Authors:  Matthew J Chiocco; Laura Shapiro Kulnane; Linda Younkin; Steve Younkin; Geneviève Evin; Bruce T Lamb
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

7.  Cluster analysis of risk factor genetic polymorphisms in Alzheimer's disease.

Authors:  C N Randall; D Strasburger; J Prozonic; S N Morris; A D Winkie; G R Parker; D Cheng; E M Fennell; I Lanham; N Vakil; J Huang; H Cathcart; R Huang; S E Poduslo
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

8.  The association of three BACE1 gene polymorphisms (exon5 C/G, intron 5 T/G and 3'UTR T/A) with sporadic Alzheimer's disease susceptibility: a meta-analysis.

Authors:  Hai Yuan; Kang Ling; Xunping Du; Pingping Ge; Shaowei Wu; Xiaotong Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

10.  The synergy factor: a statistic to measure interactions in complex diseases.

Authors:  Mario Cortina-Borja; A David Smith; Onofre Combarros; Donald J Lehmann
Journal:  BMC Res Notes       Date:  2009-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.